Olema Pharmaceuticals Inc. (OLMA)
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.94 0.00%
OLMA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $694.73M
- EPS (TTM)
- -$2.12
- Dividend yield
- None
- 52-week range
- 6.65 – 36.26
- Day range
- 7.79 – 8.23
- Volume / Avg
- 818.55K / 1.07M
- Beta
- —
- Shares outstanding
- 87.50M
- Next earnings
- Nov 9, 2026
52-week range
OLMA stock today
On Oct 7, OLMA ended the session at $7.94, adding $0.02 (0.25%), versus the S&P 500's 0.22% decline. Shares are 78.1% below their 52-week high of $36.26, set on Dec 16, 2025 and 19.4% above the 52-week low of $6.65, near the bottom of the past year's range. OLMA is down 68.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 23.9%.
Olema Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$2.12), so its P/E ratio is not meaningful. Olema Pharmaceuticals's next earnings report is expected on Nov 9, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Olema Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 9, 2026
Olema Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WVEWave Life Sciences Inc. | 3.54 | +0.57% | $697.55M | vs OLMA |
| PHARPharming Group N.V. ADS | 9.65 | -0.31% | $683.01M | vs OLMA |
| COLLCollegium Pharmaceutical Inc. | 21.93 | +0.23% | $713.94M | vs OLMA |
| NVCTNuvectis Pharma Inc. | 20.29 | +1.30% | $662.35M | vs OLMA |
| ZVRAZevra Therapeutics Inc. | 11.08 | +3.26% | $657.97M | vs OLMA |
| AVTXAvalo Therapeutics Inc. | 13.58 | -0.07% | $728.30M | vs OLMA |
| ABUSArbutus Biopharma Corporation | 4.29 | -4.24% | $657.55M | vs OLMA |
| DSGNDesign Therapeutics Inc. | 11.69 | -2.34% | $731.58M | vs OLMA |
Indexes, lists and sector
Largest Health Care stocks
Olema Pharmaceuticals stock FAQ
What is Olema Pharmaceuticals's stock price today?
OLMA last traded at $7.94 as of Oct 7, 4:00 PM EDT, up 0.25% on the day. Prices are delayed at least 15 minutes.
When is Olema Pharmaceuticals's next earnings date?
Olema Pharmaceuticals is expected to report earnings on Monday, November 9, 2026.
What is the OLMA 52-week high?
The 52-week high for OLMA is $36.26 and the 52-week low is $6.65. The stock is currently 78.1% below its high.